Dulaglutide Vs. Insulin Glargine for Type 2 Diabetes
| | To ensure that you never miss an issue, please whitelist us. |
|
|
| | This study looked at pharmacist-led diabetes education and what effect it had on improving medication adherence. Factors such as A1C, systolic blood pressure, diet, and physical activity were also examined. Pharmacists were chosen for this study due to their high levels of patient interaction. |
|
|
Several studies have been conducted to compare dulaglutide, a GLP-1 RA, with insulin glargine. Therefore, Xu et al. conducted this meta-analysis to assess the efficacy and safety of two different doses of dulaglutide (1.5 mg and 0.75 mg) versus insulin glargine. |
| |
| |
|
A study assessed the effects of detemir compared with other long-acting insulins on the risk of severe birth outcomes in women with pre-existing diabetes in a real-world setting. A randomized control trial investigated the use of detemir versus NPH insulin in combination with insulin aspart in pregnant women with type one diabetes only. |
| |
|
|
|
